Sinovac Biotech Stock Price, News & Analysis (NASDAQ:SVA)

$7.80 0.16 (2.09 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$7.80
Today's Range$7.64 - $7.84
52-Week Range$4.60 - $7.84
Volume679,828 shs
Average Volume135,292 shs
Market Capitalization$443.87 million
P/E RatioN/A
Dividend YieldN/A
Beta0.1

About Sinovac Biotech (NASDAQ:SVA)

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.


Industry, Sector and Symbol:
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Sector: Biopharmaceuticals
  • Symbol: NASDAQ:SVA
  • CUSIP: N/A
  • Web: www.sinovac.com
Sales & Book Value:
  • Annual Sales: $67.41 million
  • Price / Sales: 6.60
  • Cash Flow: $0.11 per share
  • Price / Cash: 69.12
  • Book Value: $2.49 per share
  • Price / Book: 3.13
Misc:
  • Outstanding Shares: 57,020,000
 

Frequently Asked Questions for Sinovac Biotech (NASDAQ:SVA)

What is Sinovac Biotech's stock symbol?

Sinovac Biotech trades on the NASDAQ under the ticker symbol "SVA."

How were Sinovac Biotech's earnings last quarter?

Sinovac Biotech, Ltd. (NASDAQ:SVA) announced its quarterly earnings data on Tuesday, August, 23rd. The biopharmaceutical company reported ($0.15) EPS for the quarter. The biopharmaceutical company earned $1.38 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $0.02 EPS. View Sinovac Biotech's Earnings History.

Who are some of Sinovac Biotech's key competitors?

Who are Sinovac Biotech's key executives?

Sinovac Biotech's management team includes the folowing people:

  • Weidong Yin, Chairman of the Board, President, Chief Executive Officer, Secretary (Age 48)
  • Nan Wang, Chief Financial Officer (Age 46)
  • Ming Xia, Vice President - Sales and Marketing of Sinovac Beijing (Age 38)
  • Simon J. Anderson, Independent Director (Age 53)
  • Jue Lee, Independent Director (Age 47)
  • Yuk Lam Lo, Independent Director (Age 68)
  • Meng Mei, Independent Director (Age 58)

Who owns Sinovac Biotech stock?

Sinovac Biotech's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Eqis Capital Management Inc. (0.26%), Citadel Advisors LLC (0.06%) and SG Americas Securities LLC (0.04%). Company insiders that own Sinovac Biotech stock include James Todd Parsons, Jeffrey Bacha and Scott Langille. View Institutional Ownership Trends for Sinovac Biotech.

Who sold Sinovac Biotech stock? Who is selling Sinovac Biotech stock?

Sinovac Biotech's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Sinovac Biotech.

Who bought Sinovac Biotech stock? Who is buying Sinovac Biotech stock?

Sinovac Biotech's stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC and Citadel Advisors LLC. View Insider Buying and Selling for Sinovac Biotech.

How do I buy Sinovac Biotech stock?

Shares of Sinovac Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sinovac Biotech's stock price today?

One share of Sinovac Biotech stock can currently be purchased for approximately $7.80.

How big of a company is Sinovac Biotech?

Sinovac Biotech has a market capitalization of $443.87 million and generates $67.41 million in revenue each year. The biopharmaceutical company earns ($1,070,000.00) in net income (profit) each year or ($0.11) on an earnings per share basis.

How can I contact Sinovac Biotech?

Sinovac Biotech's mailing address is 39 Shangdi Xi Road, Haidian District, BEIJING, BEJ 100085, China. The biopharmaceutical company can be reached via phone at +86-10-82890088 or via email at [email protected]


MarketBeat Community Rating for Sinovac Biotech (NASDAQ SVA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  159
MarketBeat's community ratings are surveys of what our community members think about Sinovac Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Sinovac Biotech (NASDAQ:SVA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Sinovac Biotech (NASDAQ:SVA)

Price Target History for Sinovac Biotech (NASDAQ:SVA)

Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for Sinovac Biotech (NASDAQ:SVA)

Earnings by Quarter for Sinovac Biotech (NASDAQ:SVA)

Earnings History by Quarter for Sinovac Biotech (NASDAQ SVA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/28/2016Q316$0.05$0.06$16.76 million$28.74 millionViewN/AView Earnings Details
8/23/2016Q2($0.15)$18.49 billion$1.38 billionViewListenView Earnings Details
5/26/2016Q116($0.01)$10.95 millionViewN/AView Earnings Details
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details
11/11/2015Q315($0.02)($0.03)$27.10 million$16.80 millionViewListenView Earnings Details
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details
5/15/2015Q115$0.02($0.04)$12.70 million$9.27 millionViewN/AView Earnings Details
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.04ViewListenView Earnings Details
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Sinovac Biotech (NASDAQ SVA)

Institutional Ownership Percentage: 30.71%
Insider Trades by Quarter for Sinovac Biotech (NASDAQ:SVA)
Insider Trades by Quarter for Sinovac Biotech (NASDAQ:SVA)

Insider Trades by Quarter for Sinovac Biotech (NASDAQ SVA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/20/2017Scott LangilleInsiderBuy100,000$0.27$27,000.00
4/19/2017Scott LangilleInsiderBuy50,000$0.27$13,500.00
4/18/2017Scott LangilleInsiderBuy25,000$0.26$6,500.00
4/17/2017James Todd ParsonsDirectorSell272$0.25$68.00
4/17/2017Scott LangilleInsiderBuy24,500$0.26$6,370.00
4/13/2017James Todd ParsonsDirectorSell166,500$0.25$41,625.00
4/11/2017James Todd ParsonsDirectorSell33,500$0.25$8,375.00
12/30/2015Jeffrey BachaDirectorSell10,000$0.30$2,950.00
12/29/2015Jeffrey BachaDirectorSell21,500$0.30$6,342.50
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Sinovac Biotech (NASDAQ:SVA)

Latest Headlines for Sinovac Biotech (NASDAQ SVA)

Source:
DateHeadline
Is Sinovac Biotech Ltd’s (SVA) Balance Sheet Strong Enough To Weather A Storm?Is Sinovac Biotech Ltd’s (SVA) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - November 11 at 2:13 PM
Sinovac Biotech Announces Request Hearing before Nasdaq Hearings PanelSinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel
finance.yahoo.com - November 9 at 2:11 PM
Reviewing Sinovac Biotech (SVA) and The CompetitionReviewing Sinovac Biotech (SVA) and The Competition
www.americanbankingnews.com - November 7 at 2:06 PM
Sinovac Biotech, Ltd. (SVA) Lifted to Buy at BidaskClubSinovac Biotech, Ltd. (SVA) Lifted to Buy at BidaskClub
www.americanbankingnews.com - November 5 at 10:46 PM
Comparing Sinovac Biotech (SVA) and Its CompetitorsComparing Sinovac Biotech (SVA) and Its Competitors
www.americanbankingnews.com - November 5 at 9:24 AM
Sinovac Biotech Announces Receipt of Delisting Determination Letter from NasdaqSinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq
finance.yahoo.com - November 5 at 5:25 AM
Sinovac Biotech (SVA) & Its Rivals Critical AnalysisSinovac Biotech (SVA) & Its Rivals Critical Analysis
www.americanbankingnews.com - November 3 at 11:20 PM
Contrasting Sinovac Biotech (SVA) & Its PeersContrasting Sinovac Biotech (SVA) & Its Peers
www.americanbankingnews.com - November 3 at 1:08 PM
Analyzing Sinovac Biotech (SVA) & Syndax Pharmaceuticals (SNDX)Analyzing Sinovac Biotech (SVA) & Syndax Pharmaceuticals (SNDX)
www.americanbankingnews.com - October 22 at 6:24 AM
Financial Analysis: Opiant Pharmaceuticals (OPNT) and Sinovac Biotech (SVA)Financial Analysis: Opiant Pharmaceuticals (OPNT) and Sinovac Biotech (SVA)
www.americanbankingnews.com - October 16 at 6:28 PM
Financial Survey: Sinovac Biotech (SVA) & The CompetitionFinancial Survey: Sinovac Biotech (SVA) & The Competition
www.americanbankingnews.com - October 14 at 4:14 AM
Sinovac Completed its 23-Valent Pneumococcal Polysaccharide Vaccine Phase III Clinical Trial and Filed the New Drug Application to CFDASinovac Completed its 23-Valent Pneumococcal Polysaccharide Vaccine Phase III Clinical Trial and Filed the New Drug Application to CFDA
finance.yahoo.com - October 12 at 3:45 PM
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against ChickenpoxSinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
finance.yahoo.com - October 3 at 1:09 PM
Sinobioway Consortium Updates On Offer To Buy Sinovac BiotechSinobioway Consortium Updates On Offer To Buy Sinovac Biotech
www.nasdaq.com - September 30 at 8:01 PM
Sinovacs chickenpox vaccine 87.1% effective in late-stage study; shares up 7% premarketSinovac's chickenpox vaccine 87.1% effective in late-stage study; shares up 7% premarket
seekingalpha.com - September 27 at 5:43 PM
Sinovac Biotech (SVA) versus Syndax Pharmaceuticals (SNDX) Financial AnalysisSinovac Biotech (SVA) versus Syndax Pharmaceuticals (SNDX) Financial Analysis
www.americanbankingnews.com - September 23 at 2:44 PM
Should You Be Concerned About Sinovac Biotech Ltd’s (SVA) Risks?Should You Be Concerned About Sinovac Biotech Ltd’s (SVA) Risks?
finance.yahoo.com - September 12 at 10:27 AM
Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017
finance.yahoo.com - September 9 at 9:03 AM
Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017
finance.yahoo.com - September 9 at 9:03 AM
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - September 2 at 9:11 AM
DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVADEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - September 2 at 9:11 AM
DEADLINE TOMORROW: The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)DEADLINE TOMORROW: The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - September 1 at 9:21 AM
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - September 1 at 9:21 AM
DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the FirmDEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 1 at 9:21 AM
September 1st Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sinovac Biotech Ltd.September 1st Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sinovac Biotech Ltd.
www.businesswire.com - August 31 at 10:35 AM
DEADLINE FRIDAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmDEADLINE FRIDAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 31 at 10:35 AM
Contrasting Fortress Biotech (FBIO) and Sinovac Biotech (SVA)Contrasting Fortress Biotech (FBIO) and Sinovac Biotech (SVA)
www.americanbankingnews.com - August 29 at 12:22 AM
ONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the FirmONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 9:07 AM
SVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017SVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 24 at 6:33 PM
DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. (Nasdaq: SVA) To Contact The FirmDEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. (Nasdaq: SVA) To Contact The Firm
finance.yahoo.com - August 24 at 6:33 PM
IMMINENT SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The FirmIMMINENT SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The Firm
finance.yahoo.com - August 24 at 6:33 PM
DEADLINE REMINDER: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmDEADLINE REMINDER: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 6:33 PM
8-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm8-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 6:33 PM
SEPTEMBER 1 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the FirmSEPTEMBER 1 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 1:30 PM
SINOVAC LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVASINOVAC LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVA
www.bizjournals.com - August 23 at 12:09 PM
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - August 19 at 7:54 AM
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the FirmDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 19 at 7:54 AM
SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 18 at 7:36 AM
SVA INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmSVA INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 18 at 7:36 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVAINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - August 17 at 8:01 AM
SHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmSHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 17 at 8:01 AM
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmUPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 16 at 7:53 AM
Critical Contrast: Tokai Pharmaceuticals (NVUS) and Sinovac Biotech (SVA)Critical Contrast: Tokai Pharmaceuticals (NVUS) and Sinovac Biotech (SVA)
www.americanbankingnews.com - August 15 at 8:30 PM
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmUPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 15 at 7:25 AM
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-FSinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
finance.yahoo.com - August 14 at 6:03 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017
finance.yahoo.com - August 12 at 8:13 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SV
finance.yahoo.com - August 12 at 8:13 AM
Reviewing Sinovac Biotech (SVA) and Strongbridge Biopharma PLC (SBBP)Reviewing Sinovac Biotech (SVA) and Strongbridge Biopharma PLC (SBBP)
www.americanbankingnews.com - August 11 at 10:50 AM
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - August 10 at 4:14 PM
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the FirmAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 10 at 4:14 PM

Social Media

Financials

Chart

Sinovac Biotech (NASDAQ SVA) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.